title: [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
abstract: The aim of the present study was to evaluate the hemodynamic response to the intravenous administration of the angiotensin converting enzyme-inhibitor captopril. Plasmatic renin activity was also monitored. The study population included 10 patients with chronic congestive heart failure: 3 were in the second NYHA functional class, 5 in the third, and 2 in the fourth. The patients received a first dose of 5 mg of captopril followed, after 10 min, by a second bolus-dose of 15 mg. Hemodynamic and hormonal measurements were repeated in the following 4 hours. The greatest hemodynamic effect, considered as the time of maximal mean arterial pressure and systemic vascular resistances decrease, and cardiac index increase, was noted 20 min after the first bolus dose administration. Mean arterial pressure (MAP) decreased by 13% (p less than 0.01), mean pulmonary artery pressure (MPAP) by 14% (p less than 0.05), right atrial pressure (RAP) by 30% (NS), wedge pressure (WPP) by 23% (p less than 0.01), systemic vascular resistances (SVR) by 21% (p less than 0.05), pulmonary vascular resistances by 22% (NS); cardiac index (CI) increased by 12% (p less than 0.05), stroke volume index by 10% (NS). Heart rate didn't change. The plasmatic renin activity (PRA) increased by 339% (p less than 0.01) reaching the maximal level in concomitance with the greatest hemodynamic effect. Hemodynamic changes were already noted 5 min after the first dose and lasted up to 75 min later.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: M
authors.initials: M
authors.lastname: Volpini
authors.forename: M
authors.initials: M
authors.lastname: Gargano
authors.forename: C
authors.initials: C
authors.lastname: Cuccia
authors.forename: L
authors.initials: L
authors.lastname: Dei Cas
authors.forename: P
authors.initials: P
authors.lastname: Gei
authors.forename: M
authors.initials: M
authors.lastname: Metra
authors.forename: R
authors.initials: R
authors.lastname: Moretti
authors.forename: S
authors.initials: S
authors.lastname: Riva
mesh_terms: D000328:Adult; D000368:Aged; D002216:Captopril / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002908:Chronic Disease; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
chemical_list: D002216:Captopril
vernacular_title: Effetti emodinamici della somministrazione endovenosa di captopril in pazienti affetti da scompenso cardiaco congestizio cronico.